Wisely Frugal: Ensuring sustainable funding for novel cancer therapeutics using cost-effectiveness thresholds in resource limited settings
View ORCID ProfileNuradh Joseph, Vimukthini Peiris, Vodathi Bamunuarachchi, Prasad Abeysinghe, Nadarajah Jeyakumaran, Devinda Jayathilake, Kanthi Perera, Rohini Fernandopulle, Sanjeeva Gunasekera
doi: https://doi.org/10.1101/2023.02.17.23285787
Nuradh Joseph
1District General Hospital - Hambantota, Sri Lanka
2Sri Lanka Cancer Research Group, Maharagama, Sri Lanka
MD MRCP FRCRVimukthini Peiris
2Sri Lanka Cancer Research Group, Maharagama, Sri Lanka
3District General Hospital - Vavuniya, Sri Lanka
MDVodathi Bamunuarachchi
2Sri Lanka Cancer Research Group, Maharagama, Sri Lanka
4Apeksha Hospital, Maharagama, Sri Lanka
MDPrasad Abeysinghe
2Sri Lanka Cancer Research Group, Maharagama, Sri Lanka
4Apeksha Hospital, Maharagama, Sri Lanka
MDNadarajah Jeyakumaran
2Sri Lanka Cancer Research Group, Maharagama, Sri Lanka
4Apeksha Hospital, Maharagama, Sri Lanka
MD LLBDevinda Jayathilake
2Sri Lanka Cancer Research Group, Maharagama, Sri Lanka
4Apeksha Hospital, Maharagama, Sri Lanka
MDKanthi Perera
2Sri Lanka Cancer Research Group, Maharagama, Sri Lanka
4Apeksha Hospital, Maharagama, Sri Lanka
MDRohini Fernandopulle
5Sir John Kotalawela Defence University, Kandawala, Sri Lanka
PhDSanjeeva Gunasekera
2Sri Lanka Cancer Research Group, Maharagama, Sri Lanka
4Apeksha Hospital, Maharagama, Sri Lanka
MD MSc
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted February 22, 2023.
Wisely Frugal: Ensuring sustainable funding for novel cancer therapeutics using cost-effectiveness thresholds in resource limited settings
Nuradh Joseph, Vimukthini Peiris, Vodathi Bamunuarachchi, Prasad Abeysinghe, Nadarajah Jeyakumaran, Devinda Jayathilake, Kanthi Perera, Rohini Fernandopulle, Sanjeeva Gunasekera
medRxiv 2023.02.17.23285787; doi: https://doi.org/10.1101/2023.02.17.23285787
Wisely Frugal: Ensuring sustainable funding for novel cancer therapeutics using cost-effectiveness thresholds in resource limited settings
Nuradh Joseph, Vimukthini Peiris, Vodathi Bamunuarachchi, Prasad Abeysinghe, Nadarajah Jeyakumaran, Devinda Jayathilake, Kanthi Perera, Rohini Fernandopulle, Sanjeeva Gunasekera
medRxiv 2023.02.17.23285787; doi: https://doi.org/10.1101/2023.02.17.23285787
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)